Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Gαq-coupled protein receptors

被引:136
作者
Bhatnagar, A
Sheffler, DJ
Kroeze, WK
Compton-Toth, B
Roth, BL
机构
[1] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Psychiat, Cleveland, OH 44106 USA
关键词
D O I
10.1074/jbc.M404673200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
5-Hydroxytryptamine 2A (5-HT2A) serotonin receptors are important for a variety of functions including vascular smooth muscle contraction, platelet aggregation, and the modulation of perception, cognition, and emotion. In a search for 5-HT2A receptor-interacting proteins, we discovered that caveolin-1 (Cav-1), a scaffolding protein enriched in caveolae, complexes with 5-HT2A receptors in a number of cell types including C6 glioma cells, transfected HEK-293 cells, and rat brain synaptic membrane preparations. To address the functional significance of this interaction, we performed RNA interference-mediated knockdown of Cav-1 in C6 glioma cells, a cell type that endogenously expresses both 5-HT2A receptors and Cav-1. We discovered that the in vitro knockdown of Cav-1 in C6 glioma cells nearly abolished 5-HT2A receptor-mediated signal transduction as measured by calcium flux assays. RNA interference-mediated knockdown of Cav-1 also greatly attenuated endogenous Galpha(q)-coupled P2Y purinergic receptor-mediated signaling without altering the signaling of PAR-1 thrombin receptors. Cav-1 appeared to modulate 5-HT2A signaling by facilitating the interaction of 5-HT2A receptors with Galpha(q). These studies provide compelling evidence for a prominent role of Cav-1 in regulating the functional activity of not only 5-HT2A serotonin receptors but also selected Galpha(q)-coupled receptors.
引用
收藏
页码:34614 / 34623
页数:10
相关论文
共 45 条
[1]   CAVEOLAE - WHERE INCOMING AND OUTGOING MESSENGERS MEET [J].
ANDERSON, RGW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :10909-10913
[2]   Generation of anti-peptide antibodies against serotonin 5-HT2A and 5-HT2C receptors [J].
Backstrom, JR ;
SandersBush, E .
JOURNAL OF NEUROSCIENCE METHODS, 1997, 77 (01) :109-117
[3]  
Berry SA, 1996, MOL PHARMACOL, V50, P306
[4]   The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis [J].
Bhatnagar, A ;
Willins, DL ;
Gray, JA ;
Woods, J ;
Benovic, JL ;
Roth, BL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (11) :8269-8277
[5]   Leukemia-associated Rho guanine nucleotide exchange factor promotes Gαq-coupled activation of RhoA [J].
Booden, MA ;
Siderovski, DP ;
Der, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (12) :4053-4061
[6]   Interaction of a receptor tyrosine kinase, EGF-R, with caveolins - Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities [J].
Couet, J ;
Sargiacomo, M ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30429-30438
[7]   Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled G alpha subunits G alpha(q) and G alpha(i) in caveolae in DDT1 MF-2 smooth muscle cells [J].
deWeerd, WFC ;
LeebLundberg, LMF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (28) :17858-17866
[8]   SEROTONIN INCREASES THE PRODUCTION OF INOSITOL PHOSPHATES AND MOBILIZES CALCIUM VIA THE 5-HT2 RECEPTOR IN A7R5 SMOOTH-MUSCLE CELLS [J].
DOYLE, VM ;
CREBA, JA ;
RUEGG, UT ;
HOYER, D .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 333 (02) :98-103
[9]   Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice [J].
Drab, M ;
Verkade, P ;
Elger, M ;
Kasper, M ;
Lohn, M ;
Lauterbach, B ;
Menne, J ;
Lindschau, C ;
Mende, F ;
Luft, FC ;
Schedl, A ;
Haller, H ;
Kurzchalia, TV .
SCIENCE, 2001, 293 (5539) :2449-2452
[10]   Cholesterol depletion disrupts caveolae and differentially impairs agonist-induced arterial contraction [J].
Dreja, K ;
Voldstedlund, M ;
Vinten, J ;
Tranum-Jensen, J ;
Hellstrand, P ;
Swärd, K .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (08) :1267-1272